Literature DB >> 23008409

Demand-supply of neurointerventionalists for endovascular ischemic stroke therapy.

Osama O Zaidat1, Marc Lazzaro, Emily McGinley, Randall C Edgell, Thanh Nguyen, Italo Linfante, Nazli Janjua.   

Abstract

OBJECTIVE: To estimate the needed workforce of trained neurointerventionalists (NIs) to perform endovascular therapy (ET) for eligible patients with acute ischemic stroke (AIS).
METHOD: Population and ischemic stroke incidence data were extracted with use of US Census and Centers for Disease Control and Prevention 2009 estimates. The annual "demand" is defined as the proportion of AIS patients who would meet inclusion criteria and clinical standards for ET. The "supply" is defined as the number of trained NIs and NIs in training. The "workforce" is the number of NIs needed to meet the demand (the number of eligible AIS patients) within an accessible geographic diameter. Data on NIs and NI fellowships were collected (Society of Neurointerventional Surgery [SNIS], Society of Vascular & Interventional Neurology [SVIN], Concentric Medical, and Penumbra Inc.).
RESULTS: The estimated number of NIs is close to 800, practicing within a 50-mile radius of major metropolitan areas in the United States, covering more than 95% of the US population. Approximately 40 NI fellows are graduating yearly from US training programs. In 5 years and 10 years, the number of NIs may reach 1,000 and 1,200, respectively. Currently, there are approximately 14,000 thrombectomy procedures performed in the United States each year. However, the percentage of AIS patients who may be eligible for ET in our estimation is 4% to 14%, or about 25,000 to 95,000 patients. This means that cases will occur at a rate of 26 to 97 per year in 5 years, or 22 to 81 per year in 10 years, for each NI. Providing 24/7 AIS coverage requires 2 to 3 NIs per medical center, adding to the challenge of providing manpower without diluting experience in areas of lower population density.
CONCLUSION: The current and projected number of NIs would adequately supply the future need if the proportion of patients requiring AIS endovascular therapy increases. However, 2 to 3 NIs per comprehensive stroke center would be needed to provide 24/7 AIS therapy with a sufficient number of cases per NI. A tertiary stroke center model similar to the trauma model may provide the manpower solution without compromising the quality of care.

Entities:  

Mesh:

Year:  2012        PMID: 23008409     DOI: 10.1212/WNL.0b013e31826957ef

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  Availability of endovascular therapies for cerebrovascular disease at primary stroke centers.

Authors:  Mark J Alberts; Jean Range; William Spencer; Vicki Cantwell; M J Hampel
Journal:  Interv Neuroradiol       Date:  2016-11-30       Impact factor: 1.610

Review 2.  Multimodal Diagnostic Imaging for Hyperacute Stroke.

Authors:  K D Vo; A J Yoo; A Gupta; Y Qiao; A S Vagal; J A Hirsch; D M Yousem; C Lum
Journal:  AJNR Am J Neuroradiol       Date:  2015-10-01       Impact factor: 3.825

Review 3.  Mechanical Thrombectomy Is Now the Gold Standard for Acute Ischemic Stroke: Implications for Routine Clinical Practice.

Authors:  Murugan Palaniswami; Bernard Yan
Journal:  Interv Neurol       Date:  2015-09-18

Review 4.  Endovascular Interventions in Acute Ischemic Stroke: Recent Evidence, Current Challenges, and Future Prospects.

Authors:  Ramana Appireddy; Charlotte Zerna; Bijoy K Menon; Mayank Goyal
Journal:  Curr Atheroscler Rep       Date:  2016-07       Impact factor: 5.113

Review 5.  Future directions for intra-arterial therapy for acute ischaemic stroke: is there life after three negative randomized controlled studies?

Authors:  Julian Maingard; Bernard Yan
Journal:  Interv Neurol       Date:  2014-05

6.  Regional availability of mechanical embolectomy for acute ischemic stroke in California, 2009 to 2010.

Authors:  Jay Chol Choi; Renee Y Hsia; Anthony S Kim
Journal:  Stroke       Date:  2015-02-05       Impact factor: 7.914

7.  Intravenous thrombolysis before endovascular therapy for large vessel strokes can lead to significantly higher hospital costs without improving outcomes.

Authors:  Ansaar T Rai; SoHyun Boo; Chelsea Buseman; Amelia K Adcock; Abdul R Tarabishy; Maurice M Miller; Thomas D Roberts; Jennifer R Domico; Jeffrey S Carpenter
Journal:  J Neurointerv Surg       Date:  2017-01-06       Impact factor: 5.836

Review 8.  Ischemic Strokes Due to Large-Vessel Occlusions Contribute Disproportionately to Stroke-Related Dependence and Death: A Review.

Authors:  Konark Malhotra; Jeffrey Gornbein; Jeffrey L Saver
Journal:  Front Neurol       Date:  2017-11-30       Impact factor: 4.003

9.  Diagnostic and Immunosuppressive Potential of Elevated Mir-424 Levels in Circulating Immune Cells of Ischemic Stroke Patients.

Authors:  Guangwen Li; Qingfeng Ma; Rongliang Wang; Zhibin Fan; Zhen Tao; Ping Liu; Haiping Zhao; Yumin Luo
Journal:  Aging Dis       Date:  2018-04-01       Impact factor: 6.745

10.  A population-based incidence of acute large vessel occlusions and thrombectomy eligible patients indicates significant potential for growth of endovascular stroke therapy in the USA.

Authors:  Ansaar T Rai; Aaron E Seldon; SoHyun Boo; Paul S Link; Jennifer R Domico; Abdul R Tarabishy; Noelle Lucke-Wold; Jeffrey S Carpenter
Journal:  J Neurointerv Surg       Date:  2016-07-15       Impact factor: 5.836

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.